350Annual report
2017

Stefan Oschmann
Chairman of the Executive Board and CEO
„Scientific curiosity has been a major driver of our success for 350 years. It has enabled us to pioneer new technologies. And now we are helping to shape the digital revolution.“
WHAT WE HAVE PLANNED FOR 2018
The new merck
Company video
Stefan OschmannChairman of the Executive Board and CEO

To our shareholders

The publication of our Annual Report is a good opportunity to reflect for a moment and to take stock, not only from a financial perspective. In my letter to you last year, I explained how we at Merck want to help shape technological advances. Today we can see that we successfully did so in 2017.
More
Magazine | 01
Young sources of impetus and ideas: They are experts, aspiring young scientists, founders, unconventional thinkers. How do their opinions match those of Merck? Excellently!
Magazine | 02

AN INSATIABLEPASSION FOR RESEARCH

arrow-right Created with Sketch.
We are investing in new treatments for cancer and multiple sclerosis. Around 3,000 employees are working on them at our research and development hubs in Darmstadt, Boston, Beijing, and Tokyo.
Magazine | 03

NEW WAYS OFIDENTIFYING DISEASE

arrow-right Created with Sketch.
Our customers want to capture the potential of genome medicine. Our Life Science business sector is helping them to do so.
Magazine | 04
High-tech materials from Merck are already finding their way to space today and they’re making not only antennas and windows on earth smart.

350 Years of Merck

1/13

1668 Friedrich Jacob Merck purchases a pharmacy in Darmstadt.

2/13

1754 Johann Justus Merck works during his training in Stuttgart with the “Pharmacopoea Wirtenbergica”, the most modern pharmaceutical formulary of its time.

3/13

1827 Emanuel Merck drives the transformation from a pharmacy craft to a research-based industrial company forward with the presentation of the “Novitäten Cabinet”, the cabinet of novelties.

4/13

1850 In order to ensure the continued existence of his company, Emanuel Merck establishes the partnership E. Merck together with his sons.

5/13

1879 Merck develops internationally, establishing business contacts to Asia (1832), North America (1845), South America (1851), Africa (1867), and Australia (1879).

6/13

1904 The entire factory is moved to its present-day location on Frankfurter Strasse and is expanded.

7/13

1917 The U.S. subsidiary Merck & Co., Inc., headquartered in New Jersey, USA, is expropriated and is entirely legally and economically independent today. Outside the United States and Canada, the company operates as MSD.

8/13

1987 Immunology research starts at Merck, with a focus on cancer therapy.

9/13

1995 Establishment of Merck KGaA. With a volume of DM 2.4 billion, this represents the largest public offering in German history at that time.

10/13

2007 The acquisition of Serono succeeds, making Merck a leading biotech company.

11/13

2010 The acquisition of Millipore in the United States creates a leading global partner for the life science industry.

12/13

2015 With the acquisition of the U.S. company Sigma-Aldrich, Merck further expands its leading position in the life science business. The portfolio now encompasses more than 300,000 products.

13/13

2018 Merck celebrates its anniversary.